Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Convergent Ventures is a venture capital firm founded by a diverse team of founders, scientists, and physicians with extensive experience in early-stage investments. Established in San Francisco and New York City, the firm focuses on early-stage teams that leverage science-driven technologies to advance health and sustainability. The founding team’s unique blend of expertise in science and medicine informs their investment strategy, allowing them to identify and support innovative startups.
Currently, Convergent Ventures operates with a focus on pre-seed, seed, seed-plus, and Series A funding rounds. While specific details about their assets under management (AUM) and fund sizes are not disclosed, their collaborative approach suggests a strong network and resource base. The firm emphasizes partnerships with multiple investors to enhance market and technical expertise, which is crucial for navigating the complexities of early-stage investments.
Convergent Ventures invests in differentiated technologies that exist at the intersection of data and the natural, physical, and human sciences. Their investment strategy targets sectors such as healthcare, biotech, and climate, seeking scalable business models that can deliver significant societal impacts alongside financial returns. The firm prioritizes collaboration with other investors to bolster their market and technical expertise, which enhances their ability to support portfolio companies effectively.
Investment stages include pre-seed, seed, seed-plus, and Series A, reflecting their commitment to nurturing early-stage startups. Convergent Ventures looks for teams that utilize science-driven technologies, emphasizing the importance of innovation in health and sustainability. Their focus on scalable business models indicates a preference for companies that can achieve substantial growth while addressing critical societal challenges.
Convergent Ventures has built a notable portfolio of companies that exemplify their focus on health and sustainability. Key portfolio companies include:
This diverse portfolio reflects Convergent Ventures' commitment to investing in technologies that not only promise financial returns but also contribute positively to society.
Julia Davourie, MEng: Co-Founder and General Partner. Julia brings extensive experience in early-stage investments and has a strong background in engineering.
Christina Jenkins, MD: Co-Founder and General Partner. Christina's medical expertise informs the firm's focus on healthcare investments.
Frank Levinson, PhD: Co-Founder and General Partner. Frank has a deep understanding of scientific innovation and its application in business.
Mark Alderman, Esq: Advisor. Mark provides legal expertise and guidance on regulatory matters.
Dave Clarke: Advisor. Dave offers insights into market trends and investment strategies.
Jennifer Fried: Advisor. Jennifer brings experience in healthcare and technology sectors.
Dan Gold, PhD: Advisor. Dan's scientific background supports the firm's investment thesis.
Zach Jonasson, PhD: Advisor. Zach provides expertise in data-driven technologies.
Bryan Lawlis, PhD: Advisor. Bryan's experience in biotech enhances the firm's investment approach.
Dan Riff: Advisor. Dan contributes insights into operational strategies for startups.
To pitch Convergent Ventures, founders should reach out through their website. It is advisable to include a clear overview of the business model, the technology being developed, and the potential societal impact. While specific application forms or portals are not mentioned, a well-structured pitch deck that highlights these elements is essential. Response times may vary, so founders should be prepared for a potential wait after submission.
Convergent Ventures has been actively engaging with the startup ecosystem, particularly in the sectors of health and sustainability. Their portfolio includes notable companies such as Ubicept and Novamera, indicating ongoing investment activity. However, no recent blog posts or public updates have been detected, suggesting a focus on direct engagement with portfolio companies rather than public announcements.
What are Convergent Ventures' investment criteria?
Convergent Ventures focuses on early-stage investments in differentiated technologies at the intersection of data and the natural, physical, and human sciences. They target sectors such as healthcare, biotech, and climate, seeking scalable business models that can deliver significant societal impacts and financial returns.
How can founders apply or pitch to Convergent Ventures?
Founders interested in pitching to Convergent Ventures are encouraged to reach out through their website. Specific contact details are not provided, but they emphasize the importance of presenting a clear and compelling business model that aligns with their investment focus.
What makes Convergent Ventures different from other VC firms?
Convergent Ventures distinguishes itself through its emphasis on science-driven technologies and collaboration with multiple investors. Their founding team’s background in science and medicine enhances their ability to evaluate and support innovative startups effectively.
What is the geographic scope of Convergent Ventures?
The firm primarily focuses on the North American market, investing in early-stage companies that operate within this region.
What is the typical check size for investments?
While specific check sizes are not disclosed, Convergent Ventures invests in pre-seed, seed, seed-plus, and Series A funding rounds, indicating a range of investment amounts tailored to the needs of early-stage startups.
What kind of post-investment involvement can founders expect?
Convergent Ventures emphasizes collaboration and support for their portfolio companies, leveraging their network and expertise to assist in navigating challenges and scaling operations.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.